Short‐Term BMP‐2 Expression Is Sufficient for In Vivo Osteochondral Differentiation of Mesenchymal Stem Cells

Overview of attention for article published in Stem Cells, December 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

policy: 1 policy source

patent: 3 patents

Readers on

mendeley: 107 Mendeley
connotea: 1 Connotea

So far, Altmetric has seen 3 patents that reference this research output.

Biomimetic biphasic 3D nanocomposite scaffold for osteochondral regeneration

Grant US-10406261-B2

United States of America

CELL-PERMEABLE BONE MORPHOGENETIC PROTEIN (CP-BMP) RECOMBINANT PROTEIN AND USE THEREOF

Application WO-2017034330-A1

World Intellectual Property Organisation (WIPO)

AUTOLOGOUS HUMAN ADULT PLURIPOTENT VERY SMALL EMBRYONIC-LIKE (hVSEL) STEM CELL…

Application US-20140112891-A1

United States of America

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.